BIJSLUITER: INFORMATIE VOOR DE GEBRUIKER MOMETASONE TEVA 50 MICROGRAM/VERSTUIVING, NEUSSPRAY, SUSPENSIE mometasonfuroaat Lees go
Mometasone Furoate Market accounted for US$ 1,182.9 million in 2022 and is projected to register a CAGR of 7.4 2030 | Cipla, Teva Pharmaceuticals, Glenmark Pharmaceuticals, AdvaCare Pharma, | Medgadget